Diana V. Minukhina

Diana V. Minukhina

Auto-generated profile, based on publicly available information

Diana V. Minukhina

Kharkiv National Medical University, Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
Verified
Journal Article
Open access
ТZТ. S. Zaikina
Т. S. Zaikina
DMD. V. Minukhina
D. V. Minukhina
PRP. I. Rynchak
P. I. Rynchak
GTG. Yu. Tytova
G. Yu. Tytova
VZV. I. Zolotaikina
V. I. Zolotaikina
The purpose of the study was to investigate the effect of reperfusion therapy on the levels of endothelial nitric oxide synthase in patients with acute myocardial infarction and concomitant type 2 diabetes mellitus. Materials and methods. The study involved patients with acute myocardial infarction, who were divided into groups depending on the presence of type 2 diabetes mellitus and the therapy performed for them: group 1 – 58 patients with acute myocardial infarction and diabetes mellitus who underwent percutaneous coronary intervention; group 2 – 15 patients with acute myocardial infarction and diabetes mellitus who underwent exclusively conservative treatment; group 3 – 40 patients with acute myocardial infarction without diabetes who underwent percutaneous coronary intervention; group 4 – 17 patients with acute myocardial infarction without diabetes, who underwent exclusively conservative treatment. Results and discussion. According to the obtained results, in patients with concomitant type 2 diabetes mellitus, significantly lower levels of endothelial nitric oxide synthase were revealed, compared with patients without disturbances in carbohydrate metabolism, which indicates deeper impairments of endothelial function against the background of hyperglycemia and insulin resistance. Analysis of the effect of reperfusion therapy showed a statistically significant increase in the level of endothelial nitric oxide synthase both in the group of patients with concomitant disorders of carbohydrate metabolism and without them, which indicates an improvement in the processes of endothelium-dependent dilation, regardless of the presence or absence of type 2 diabetes mellitus. The obtained results testify to the positive effect of percutaneous coronary intervention at the level of eNOS, which, in our opinion, will help to improve the vasodilating properties of vascular endothelium and prevent a complicated course of acute myocardial infarction. Conclusion. The patients with acute myocardial infarction and concomitant type 2 diabetes mellitus have significantly lower levels of endothelial nitric oxide synthase levels than patients without type 2 diabetes mellitus that indicates deep violations of endothelial function against background of metabolic changes associated with insulin resistance and hyperglycemia. Reperfusion therapy accelerates its restoration regardless of the presence or absence of type 2 diabetes mellitus

15 March 2024 in Clinical and Preventive Medicine
Verified
Journal Article
Open access
PDF file
DMDiana V. Minukhina
Diana V. Minukhina
PKPavlo G. Kravchun
Pavlo G. Kravchun
DMDmitriy V. Minukhin
Dmitriy V. Minukhin
DYDenys Oleksandrovych Yevtushenko
Denys Oleksandrovych Yevtushenko
VKVasyl V. Kritsak
Vasyl V. Kritsak
VTVolodymyr V. Tkachenko
Volodymyr V. Tkachenko
Introduction. Despite the major successes achieved in the treatment of acute coronary syndromes (ACS), acute myocardial infarction (AMI) remains the main cause of death among the working-age population of Ukraine. The means of treatment of interventional cardiology can actually reduce the mortality of patients with ACS, improve the course of the acute period of the disease and ensure less reduction in the functional capabilities of the heart in the future. Among the many pathogenetic mechanisms of vascular inflammation in coronary heart disease and type 2 diabetes, endothelial dysfunction is the determining factor. The aim of the study. To evaluate the levels of plasminogen activator inhibitor type 1, asymmetric dimethylarginine and endothelial nitric oxide synthase on the 10-14th day in patients depending on the presence or absence of concomitant diabetes type 2 and the type of reperfusion therapy. Materials and methods. 130 patients with acute myocardial infarction were examined, who were divided into 2 groups: 1 group consisted of patients with acute myocardial infarction with accompanying type 2 diabetes (n=73), 2 group – patients with acute myocardial infarction without type 2 diabetes (n =57). The quantitative content of the plasminogen activator inhibitor type 1 (PAI-1) was determined by the immunoenzymatic method using a commercial test system manufactured by Technoclone PAI-1 ELISA Kit (Austria), endothelial nitric oxide synthase (NOS) – Enzyme-Linked Immunosorbent Assay (ELISA) Kit For Nitric Oxide Synthase Endothelial, asymmetric dimethylarginine (ADMA) – Immunodiagnostik ADMA ELISA Kit (Austria). Results. Percutaneous coronary intervention (PCI) contributes to a more significant decrease in the content of the marker of endothelial dysfunction – ADMA and an increase in NOS on the 10-14th day of acute myocardial infarction in comparison with standard therapy. During PCI, the level of PAI-1 did not reliably change during treatment due to post-inflammatory and post-traumatic activation of platelets in the vascular wall. Conclusions. In patients with acute myocardial infarction with type 2 diabetes mellitus, percutaneous coronary intervention contributes to a significant decrease in the content of asymmetric dimethylarginine and an increase in NOS on the 10-14th day of acute myocardial infarction, but was not accompanied by a significant decrease in the level of PAI-1, which in general indicates positive effect of performed myocardial revascularization. Вступ. Незважаючи на серйозні успіхи, досягнуті у лікуванні гострих коронарних синдромів (ГКС), гострий інфаркт міокарда (ГІМ) залишається основною причиною смертності працездатного населення України. Засоби лікування інтервенційної кардіології дозволяють фактично знизити смертність хворих з ГКС, покращити перебіг гострого періоду захворювання та забезпечити менше зниження функціональних можливостей серця в майбутньому. Серед багатьох патогенетичних механізмів запалення судин при ішемічній хворобі серця та цукровому діабеті 2 типу визначальним є ендотеліальна дисфункція. Мета. Оцінити рівні інгібітора активатора плазміногену 1 типу, асиметричного діметіларгінину та ендотеліальної синтази оксиду азоту на 10-14-й день у хворих в залежності від наявності або відсутності супутнього цукрового діабету 2 типу та виду репер фузійної терапії. Матеріали та методи. Обстежено 130 хворих на гострий інфаркт міокарда, яких було розподілено на 2 групи: 1 групу склали хворі на гострий інфаркт міокарда з супутнім цукровим діабетом 2 типу (n=73), 2 групу ‒ хворі на гострий інфаркт міокарда без цукрового діабету 2 типу (n=57). Кількісний вміст інгібітора активатора плазміногену 1 типу (ІАП-1) визначали імуноферментним методом з використанням комерційної тест-системи виробництва фірми Technoclone PAI-1 ELISA Kit (Австрія), ендотнліальної синтази оксиду азоту (NOS) – Enzyme-Linked Imunosorbent Assay (ELISA) Kit For Nitric Oxide Synthase Endothelial, асиметричного діметіларгінину (АДМА) – Immunodiagnostik ADMA ELISA Kit (Австрія). Результати. Проведення черезшкірного коронарного втручання сприяє більш значному зниженню вмісту маркеру ендотеліальної дисфункції ‒ АДМА та підвищенню NOS на 10-14-й день гострого інфаркта міокарда у порівнянні зі стандартною терапією. При проведенні ЧКВ рівень ІАП-1 достовірно не змінювався у динаміці лікування за рахунок постзапальної та посттравматичної активації тромбоцитів у судинній стінці. Висновки. У хворих на гострий...

30 September 2018 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
DMD. V. Minukhina
D. V. Minukhina
VBV. D. Babadzhan
V. D. Babadzhan
VBV. V. Boyko
V. V. Boyko
VMV. V. Minukhin
V. V. Minukhin
DYDenys Oleksandrovych Yevtushenko
Denys Oleksandrovych Yevtushenko
Objective. To estimate the levels of inhibitor of the plasminogen activator type 1 (ІPA-1) and аsymmetrical dimetilarginin (АDMА) in patients with an acute myocardial infarction (AMI), depending on presence or absence of diabetes mellitus type II (DM2) and character of the coronary arteries (CA) affection, аs well as their prognostic significance concerning degree of the coronary vessels atherosclerotic changes. Маterials and methods. There were examined 130 patients, 44 (33,85%) - women and 86 (66.15%) - men. All the patients were distributed into two groups: the main - 73 patients with AMI and concurrent DM2, among which there were 43 men and 30 women, average ageing (62.73 ± 1.39) yrs old, and a comparative one - 57 patients with AMI without DM2, including 43 men and 14 women, average ageing (63.98 ± 1.47) yrs old. Control group consisted of 20 practically healthy persons (including 10 men and 10 women, average ageing (60.85 ± 1.37) yrs old). In all the patients a coronarography in standard projections was conducted, using angiograph Siemens Axiom Artis. The ADMA content was established, using immunoassay method, with the help of a commercially available test-system «Immunodiagnostik», manufactured by the ADMA Xpress ELISA Kit (Аustria) company, ІPA-1 - by immunoassay method as well, using a commercially available test-system, manufactured by Technoclone PAI-1 ELISA Kit (Аustria) firm. Results. In the patients, suffering AMI, not depending on the DM2 presence or absence, the ІPА-1 та АDМА levels are raised, comparing with a control group (р < 0.05). In the patients, suffering hemodynamically significant stenosis (HSS) of CА (70% and more) there were registered the raised levels of ІPA-1 and АDМА while the DM2 presence or absence (р < 0.05). In the patients, suffering an AMI and diffuse affection (DA) of CА, with concurrent DM2 or without it, the levels of ІPA-1 and АDMA were trustworthily higher, than in the patients without DA of CA (р < 0.05). Conclusion. Comparison of squares under the ROC-curves have shown, that IPA-1 has more diagnostic significance for prognostication of DA of CA in patients with an AMI and concurrent DM2, than АDМА. It is expedient to determine the levels of ІPA-1 and АDМА for prognostication of HSS of CA and diagnosis of the coronary bed DA with the objective to prevent the development of the AMI complications.

23 November 2018 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
DMD. V. Minukhina
D. V. Minukhina
VBV. D. Babadzhan
V. D. Babadzhan
PKP. H. Kravchun
P. H. Kravchun
VMV. V. Minukhin
V. V. Minukhin
Изменения в системе асимметричный диметиларгинин – NO-синтаза у больных с острым инфарктом миокарда и сахарным диабетом 2 типа